Combination of biomarkers for the detection and evaluation of hepatitis fibrosis
US9624541B2 · kind B2 · utility
3Cited by
2References
3Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 9, 2012 |
| Grant date | Apr 18, 2017 |
| Priority date | — |
| Expiry date | Feb 6, 2033 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/7052
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The application concerns means for determining the stage of hepatic tissue damage, in particular the hepatic fibrosis score of subjects infected with one or more hepatitis viruses. In particular, the means of the invention involve measuring the levels of expression of selected genes, said selected genes being:
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.